Unilife Corp  

(Public, NASDAQ:UNIS)   Watch this stock  
Find more results for UNIS
3.20
+0.01 (0.31%)
Dec 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.15 - 3.22
52 week 2.00 - 5.80
Open 3.18
Vol / Avg. 207,165.00/677,889.00
Mkt cap 355.19M
P/E     -
Div/yield     -
EPS -0.68
Shares 111.00M
Beta 1.14
Inst. own 39%
Feb 2, 2015
Q2 2015 Unilife Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 2, 2014
Unilife Corp at Piper Jaffray Healthcare Conference
Nov 13, 2014
Unilife Corp Annual Shareholders Meeting - Webcast
Nov 10, 2014
Q1 2015 Unilife Corp Earnings Call
Nov 10, 2014
Q1 2015 Unilife Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin -1613.19% -394.17%
Operating margin -1369.28% -349.89%
EBITD margin - -322.12%
Return on average assets -109.89% -77.11%
Return on average equity -5170.39% -277.50%
Employees 209 -
CDP Score - -

Address

250 Cross Farm Lane
YORK, PA 17406
United States - Map
+1-717-3843400 (Phone)
+1-717-3843401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Company's technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.

Officers and directors

Alan D. Shortall Chairman of the Board, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Ramin Mojdehbakhsh Ph.D. President, Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
Slavko James Joseph Bosnjak Deputy Vice Chairman, Lead independent Director
Age: 65
Bio & Compensation  - Reuters
Dennis P. Pyers Interim Chief Financial Officer, Chief Accounting Officer, Vice President, Controller
Age: 53
Bio & Compensation  - Reuters
John Ryan J.D. Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Kevin Sellers Senior Vice President - Marketing and Communications
Bio & Compensation  - Reuters
Mark V. Iampietro Vice President - Quality and Regulatory Affairs
Age: 61
Bio & Compensation  - Reuters
Jeff Carter Non-Executive Director
Age: 56
Bio & Compensation  - Reuters
William Galle Independent Non-Executive Director
Age: 75
Bio & Compensation  - Reuters
John M. Lund Independent Non-Executive Director
Age: 48
Bio & Compensation  - Reuters